MT-II (Melanotan II)
$40.00
MT-II (Melanotan II) is supplied as a high-purity lyophilized research peptide for laboratory research applications.
✔ 10mg Strength
✔ 99%+ Purity
✔ Lyophilized Powder
✔ Laboratory Grade
✔ Research Peptides
For Research Use Only.
Not For Human Consumption.
Out of stock
Description
Product Overview
MT-II (Melanotan II) is supplied as a high-purity lyophilized research peptide intended exclusively for laboratory and scientific research applications.
This product is categorized under Research Peptides and is commonly referenced in laboratory studies involving melanocortin receptor biology, peptide pharmacology, pigmentation research, and receptor signaling pathways.
Research Background
MT-II (Melanotan II) is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH) that has been referenced in scientific literature for research involving melanocortin receptor activity, pigmentation biology, peptide signaling, and neuroendocrine pathways. Laboratory investigations continue to explore its biological activity within experimental research models. Apex Peptides supplies this material strictly for research use only.
Common Research Areas
- Melanocortin Receptor Biology
- Pigmentation Research
- Neuroendocrine Signaling
- Peptide Pharmacology
- Receptor Signaling Pathways
Product Specifications
- Product Name: MT-II (Melanotan II)
- Strength: 10mg
- Purity: ≥99%
- Appearance: Lyophilized Powder
- Category: Research Peptides
- Molecular Formula: C50H69N15O9
- Molecular Weight: 1,024.18 g/mol
- CAS Number: 121062-08-6
- Storage: Store refrigerated in a cool, dry environment. Protect from excessive heat and light.
Research Use Notice
For Research Use Only.
Not For Human Consumption.
This product is intended exclusively for laboratory and scientific research by qualified professionals. It is not intended to diagnose, treat, cure, or prevent any disease and has not been evaluated for human or veterinary use.
Additional information
| Title | Default Title |
|---|






Reviews
There are no reviews yet.